5/9/2019 12:51:33 PM - Reported earnings +38% on +9% sales revenues for the Mar '19 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). Consolidating above its 50 DMA line. Completed a Secondary Offering on 8/14/17. New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
10/19/2017 1:02:07 PM - Gapped down today violating its 50 DMA line again with a volume-driven loss. Completed a Secondary Offering on 8/14/17 and prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
10/12/2017 12:20:59 PM - Recently rebounded above its 50 DMA line ($56.72). Completed a Secondary Offering on 8/14/17 and prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
9/15/2017 12:44:21 PM - Gapped down today testing its 50 DMA line ($56.33) again. Completed a Secondary Offering on 8/14/17 and prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
8/15/2017 12:27:20 PM - Tested its 50 DMA line ($54.65) after proposing a Secondary Offering, abruptly retreating from its 52-week high. Prior mid-day reports cautioned members - "Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
8/14/2017 12:42:17 PM - Gapped down on the prior session and tested its 50 DMA line ($54.49) after proposing a Secondary Offering, abruptly retreating from its 52-week high. The 8/11/17 mid-day report cautioned members - "Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
8/11/2017 1:07:52 PM - Gapped down today and tested its 50 DMA line after proposing a Secondary Offering, abruptly retreating from its 52-week high. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
8/8/2017 12:17:27 PM - Gapped up today and hit another new 52-week high. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
8/1/2017 11:45:45 AM - Gapped up today and hit a new 52-week high. Last noted with caution in the 6/22/17 mid-day report - "Reported earnings +5% on +7% sales revenues for the Mar '17 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
6/22/2017 12:58:27 PM - Perched at its 52-week high. Reported earnings +5% on +7% sales revenues for the Mar '17 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
5/10/2017 12:04:52 PM - Reported earnings +5% on +7% sales revenues for the Mar '17 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
12/15/2015 12:52:45 PM - Again slumping near its 200 DMA line which acted as support during its consolidation since noted in the 11/04/15 mid-day report with caution - "Reported earnings +23% on +42% sales revenues for the Sep '15 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
12/9/2015 12:48:58 PM - Slumping near its 200 DMA line which acted as support during its consolidation since last noted in the 11/04/15 mid-day report with caution - "Reported earnings +23% on +42% sales revenues for the Sep '15 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
11/4/2015 12:44:39 PM - Slumping below its 50 DMA line. The 11/03/15 mid-day report cautioned members - "Reported earnings +23% on +42% sales revenues for the Sep '15 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15."
11/3/2015 12:57:40 PM - Pulling back from its 52-week high. Reported earnings +23% on +42% sales revenues for the Sep '15 quarter. Fundamental concerns remain as prior quarters were not strong and steady above the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15, 5/20/15, and 8/11/15.
8/12/2015 1:06:16 PM - Completed yet another Secondary Offering on 8/11/15, pulling back from its 52-week high. Reported earnings +29% on +42% sales revenues for the Jun '15 quarter, but fundamental concerns remain. Earnings rose +17% on +41% sales revenues in the Mar '15 quarter, below the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15 and 5/20/15.
8/11/2015 1:07:26 PM - Gapped down today after proposing yet another Secondary Offering, pulling back from its 52-week high. Reported earnings +29% on +42% sales revenues for the Jun '15 quarter, but fundamental concerns remain. Earnings rose +17% on +41% sales revenues in the Mar '15 quarter, below the +25% minimum guideline (C criteria). New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, 3/09/15 and 5/20/15.
8/4/2015 12:39:40 PM - Pulling back from its 52-week high today with a 2nd consecutive volume-driven loss. Completed yet another Secondary Offering on 5/20/15 when noted in the mid-day report with caution- "Reported earnings +17% on +41% sales revenues in the Mar '15 quarter, below the +25% minimum guideline (C criteria), raising fundamental concerns. Undercut is 50 DMA line during its consolidation then rebounded and rallied to new highs since last noted in the 4/20/15 mid-day report. New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, and 3/09/15."
7/31/2015 1:09:42 PM - Gapped up today for a new 52-week high. Completed yet another Secondary Offering on 5/20/15 when last noted in the mid-day report with caution- "Reported earnings +17% on +41% sales revenues in the Mar '15 quarter, below the +25% minimum guideline (C criteria), raising fundamental concerns. Undercut is 50 DMA line during its consolidation then rebounded and rallied to new highs since last noted in the 4/20/15 mid-day report. New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, and 3/09/15."
5/20/2015 1:03:05 PM - Gapped down from its 52-week high today after proposing yet another Secondary Offering. Reported earnings +17% on +41% sales revenues in the Mar '15 quarter, below the +25% minimum guideline (C criteria), raising fundamental concerns. Undercut is 50 DMA line during its consolidation then rebounded and rallied to new highs since last noted in the 4/20/15 mid-day report. New CEO on 1/08/15. After its Jan '13 IPO at $19 it completed Secondary Offerings on 11/09/13, 12/03/13, 3/07/14, and 3/09/15.
4/20/2015 12:49:57 PM - Slumping near its 50 DMA line today with a loss on higher volume. Its brief consolidation is not recognized as a sound base, and it was last noted in the 3/27/15 mid-day report - "Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Completed yet another Secondary Offering on 3/09/15 perched at all-time highs. Replaced its CEO on 1/08/15. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14."
3/27/2015 12:26:35 PM - Extended from any sound base. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Completed yet another Secondary Offering on 3/09/15 perched at all-time highs. Replaced its CEO on 1/08/15. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
3/16/2015 12:25:48 PM - Completed yet another Secondary Offering on 3/09/15 perched at all-time highs. Replaced its CEO on 1/08/15, and it rallied above its 50 DMA line with a big volume-driven gain on 2/18/15. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
3/6/2015 12:37:01 PM - Pulling back today after proposing a Secondary Offering, encountering distributional pressure after recently wedging into new high territory with gains lacking great volume conviction. Replaced its CEO on 1/08/15, and it rallied above its 50 DMA line with a big volume-driven gain on 2/18/15. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
2/20/2015 1:02:46 PM - Pulling back today, encountering distributional pressure. Replaced its CEO on 1/08/15, and it rallied above its 50 DMA line this week with big volume-driven gains touching a new 52-week high. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
2/18/2015 12:27:44 PM - Replaced its CEO on 1/08/15, and it has been trading below its 50 DMA ($45.18) line. Today's volume-driven gain is challenging that important short-term average, and it faces resistance due to overhead supply up to the $48 level. Quarterly earnings increases through Dec '14 have been above the +25% minimum guideline (C criteria). After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
1/12/2015 12:35:22 PM - Quarterly earnings increases through Sep '14 have been above the +25% minimum guideline (C criteria). Extended from any sound base, it retreated from its 52-week high with a volume-driven loss on the prior session after replacing its CEO, slumping near its 50 DMA line. After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
1/9/2015 12:25:51 PM - Quarterly earnings increases through Sep '14 have been above the +25% minimum guideline (C criteria). It is extended from any sound base and retreating from its 52-week high with a volume-driven loss today, slumping near its 50 DMA line. After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14.
11/28/2014 11:20:23 AM - Quarterly earnings increases through Sep '14 have been above the +25% minimum guideline (C criteria). Gapped up today and hit a new 52-week high, getting extended from any sound base. After its Jan '13 IPO at $19 it completed Secondary Offerings in Aug and Dec '13 and on 3/07/14 .